Skip to Content

Inspire Medical Systems, Inc.

Securities Class Action

  • Date:
  • 8/7/2025
  • Company Name:
  • Inspire Medical Systems, Inc.
  • Stock Symbol:
  • INSP
  • Status:
  • Investigating
  • Filing Date:
  • 12/22/2023

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) on behalf of Inspire stockholders. Our investigation concerns whether Inspire has violated the federal securities laws and/or engaged in other unlawful business practices.

On August 5, 2025, Inspire issued a press release announcing better-than-expected second quarter fiscal 2025 results, but surprisingly also slashed its full-year guidance from anticipated earnings of $2.20 - $2.30 on revenue of $940m - $955m down to earnings of $0.40 - $0.50 on revenue of $900m - $910m. This follows Inspire raising its earnings guidance only one quarter ago. Management blamed the guidance setback on slowdowns related to the recent rollout of Inspire V. The company disclosed that the commercial rollout "encountered certain headwinds" such as centers failing to complete training and onboarding criteria, customer delays, technical Medicare adoption delays, and continued higher demand for Inspire IV devices.

Following this news, Inspire's stock price fell by $46.44 per share to open at $83.51 per share.

If you purchased or otherwise acquired Inspire shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.
Contact Instructions
Please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com with any questions regarding the case. 
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Inspire Medical Systems. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: